Abstract. Anterior When anterior pituitary glands were incubated without hypothalami, GABA, bicuculline and picrotoxin had no effect on the release of Prl or GH. However, GABA inhibited the release of both hormones in a concentration-related manner, when anterior pituitary glands were co-incubated with hypothalami. This inhibition was blocked by both bicuculline and picrotoxin.
In avian species stimulatory and inhibitory hypo¬ thalamic factors control prolactin (Prl) release, although whereas the predominant influence is inhibitory in mammals, it is stimulatory in birds (Harvey et al. 1982 ; Hall 1984) . Stimulatory and inhibitory factors affecting growth hormone (GH) secretion (growth hormone releasing factor (GRF) and somatostatin (SRIF), respectively) have also been isolated from the mammalian hypothalamus and these have effects in birds similar to those in mammalian species (Harvey 1983; Harvey et al., in press ). In avian species, it is also well established that the release of the hypothalamic factors affecting Prl and GH secretion is regulated by various neurotransmitters and neuromodulators (Weiner & Ganong 1978; Harvey 1983) . In particular the Prl releasing activity of the chicken hypo¬ thalamus has thus been shown to be modified by noradrenaline, serotonin, dopamine, acetylcholine as well as prostaglandins (Harvey et al. 1982 ; press), substances which also affect growth hormone secretion (Harvey 1983; Hall et al., in press ).
GABA appears to be an important inhibitory synaptic transmitter in the central nervous system (CNS) and is found in high concentrations in the hypothalamus (McCann et al. 1982; Racagnini et al. 1982) . In mammalian species GABA has been reported to have stimulatory and inhibitory effects on both Prl and GH secretion (reviewed by Elias et al. 1982; McCann et al. 1982; Racagnini et al. 1982 ). The influence of GABA on avian Prl secre¬ tion suggests that it is inhibitory, reducing hypothalami-induced Prl secretion (Harvey et al. 1982) .
GABA may also suppress GH secretion in birds, since its systemic administration lowered the plasma GH level in chickens (Harvey 1983) .
Histamine is also present in the CNS (Schwartz 1977 ) and functions as a neurotransmitter (Schwartz 1977; Nistico et al. 1980) and it has been shown to stimulate Prl and GH release in mam¬ malian species (Weiner & Ganong 1978) . In birds data suggest that histamine may inhibit GH secre¬ tion in vivo (Harvey 1983) and enhance Prl secre¬ tion both in vitro and in vivo (Harvey et al. 1982) .
In (Hall et al. 1975; propriately diluted and stored at -20°C.
Tissues were incubated in medium containing hista¬ mine dihydrochloride (10~9 to 10"6m), the histamine H^r eceptor antagonist diphenhydramine hydrochloride (10~6 m), or combinations of both drugs, gamma-aminobutyrate sodium salt (GABA, 10"9 to 10"* M), the GABA antagonists bicuculline (10"6m) and picrotoxin (10"6m) (Fig. 2) . However, at doses of 10"8M-10-6M, GABA inhibited the hypo- (Harvey et al. 1982) , although this is not a consistent finding (Rivier & Vale 1977) and may involve interaction with non-histaminergic receptors.
GH release from the pituitary-hypothalami coincubation was increased by several doses of hista¬ mine, although the highest dose was not the most effective. The nature of this response is very simi¬ lar to the effects of other amines on pituitary hormone secretion (Elias et al. 1982 ). This stimula¬ tion of GH release may result from the stimulation of a hypothalamic GH releasing factor or inhibition of an inhibiting factor, since histamine had no direct effect on pituitary GH secretion. The stimu¬ latory effect of histamine on GH release is consi¬ stent with in vivo effects in mammalian species, in which Hi antagonists block the stimulatory effects of morphine (Rivier & Vale 1977) and enkephalin (Casaneuva et al. 1981) on GH secretion. Although pharmacological histamine administration lowered the plasma GH concentration in immature chick¬ ens (Harvey 1983) this is likely to be due to a peripheral effect, since histamine does not cross the blood-brain barrier (Schwartz 1977 (Racagnini et al. 1982) . At high concentrations GABA may also inhibit prolactin release directly from incubated chicken pituitaries (Harvey et al. 1982) , althouth not at the doses used in the present study. The inhibitory effect of GABA on hypothalamus-induced Prl secretion in these studies differs from many mammalian studies, but may be due to its stimulation of dopamine release (McCann et al. 1982) . Dopamine inhibits Prl secre¬ tion in the fowl (Harvey et al. 1982 ).
Dopamine and other catecholamines inhibit GH secretion in the fowl (Harvey 1983) and therefore may mediate the inhibitory effect of GABA on hypothalamus-induced growth hormone release (Fig. 2) . Dopamine has similarly been implicated in mediating the inhibitory and stimulatory effects of GABA on GH secretion in mammalian species, the dopamine response to GABA being biphasic (Elias et al. 1982 ). However, the dual effect of GABA on mammalian growth hormone secretion was sug¬ gested by Fisk et al. (1981) to be due to inhibition of hypothalamic somatostatin release and to an inhibi¬ tion of growth hormone-releasing hormone (GRH) secretion from the hypothalamus. In the present study the in vitro reduction in GH release by GABA treatment is unlikely to be mediated by an inhibition of GRH secretion, since incubation with the hypothalamus did not increase the basal level of pituitary GH release.
